An extended antibody microarray for surface profiling metastatic melanoma.
An antibody microarray was developed for profiling the surface proteome of melanoma cells, which may facilitate melanoma sub-classification and provide important prognostic information useful in predicting the clinical behavior of the melanoma (e.g., likely sites of metastatic spread), patient outcome and treatment response. Forty-eight antibodies were selected based on their correlation with melanoma development, progression and/or prognosis and printed on nitrocellulose slides. The immobilised antibodies capture live cells expressing corresponding antigens to produce a cell binding dot pattern representing the surface antigen profile (immunophenotype) of the melanoma. Surface antigen signatures were determined for a normal melanocyte and 6 melanoma cell lines and cell suspensions prepared from 10 surgically excised melanoma lymph node metastases. A procedure for obtaining separate surface antigen profiles for melanoma cells and leukocytes from clinical lymph node samples was also developed using anti-CD45 magnetic beads. The capture of live, bead-bound leukocytes on these antibody microarrays provides a significant enhancement of this microarray technology. The antibody microarray will be used to profile panels of surgically excised melanoma lymph node metastases (melanoma and leukocyte fractions) to determine whether the immunophenotypes correlate with clinicopathological characteristics, disease progression and clinical outcome.
Kaufman
Kimberley L
KL
School of Molecular and Microbial Biosciences, The University of Sydney, NSW, Australia. K.Kaufman@usyd.edu.au
Belov
Larissa
L
Huang
Pauline
P
Mactier
Swetlana
S
Scolyer
Richard A
RA
Mann
Graham J
GJ
Christopherson
Richard I
RI
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000906:Antibodies / Q000276:immunology*; D015703:Antigens, CD / Q000032:analysis / Q000276:immunology / Q000378:metabolism; D000954:Antigens, Surface / Q000032:analysis* / Q000276:immunology / Q000378:metabolism; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D008544:Melanocytes / Q000737:chemistry / Q000378:metabolism; D008545:Melanoma / Q000737:chemistry* / Q000175:diagnosis* / Q000276:immunology / Q000378:metabolism; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D040081:Protein Array Analysis / Q000379:methods*; D014407:Tumor Cells, Cultured
D000906:Antibodies; D015703:Antigens, CD; D000954:Antigens, Surface